126 related articles for article (PubMed ID: 16778171)
1. NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.
Chang PY; Draheim K; Kelliher MA; Miyamoto S
Cancer Res; 2006 Jun; 66(12):6008-13. PubMed ID: 16778171
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor-kappaB dimer exchange promotes a p21(waf1/cip1) superinduction response in human T leukemic cells.
Chang PY; Miyamoto S
Mol Cancer Res; 2006 Feb; 4(2):101-12. PubMed ID: 16513841
[TBL] [Abstract][Full Text] [Related]
3. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
5. Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
Terme JM; Wencker M; Favre-Bonvin A; Bex F; Gazzolo L; Duc Dodon M; Jalinot P
J Virol; 2008 Aug; 82(16):7913-22. PubMed ID: 18495761
[TBL] [Abstract][Full Text] [Related]
6. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor-alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50.
Aoudjit F; Brochu N; Bélanger B; Stratowa C; Hiscott J; Audette M
Cell Growth Differ; 1997 Mar; 8(3):335-42. PubMed ID: 9056676
[TBL] [Abstract][Full Text] [Related]
7. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
8. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells.
Cardoso BA; de Almeida SF; Laranjeira AB; Carmo-Fonseca M; Yunes JA; Coffer PJ; Barata JT
Leukemia; 2011 Oct; 25(10):1578-86. PubMed ID: 21647153
[TBL] [Abstract][Full Text] [Related]
9. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
10. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the hTERT promoter by the proto-oncogenic protein TAL1.
Terme JM; Mocquet V; Kuhlmann AS; Zane L; Mortreux F; Wattel E; Duc Dodon M; Jalinot P
Leukemia; 2009 Nov; 23(11):2081-9. PubMed ID: 19587703
[TBL] [Abstract][Full Text] [Related]
12. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
13. The SCL/TAL1 Transcription Factor Represses the Stress Protein DDiT4/REDD1 in Human Hematopoietic Stem/Progenitor Cells.
Benyoucef A; Calvo J; Renou L; Arcangeli ML; van den Heuvel A; Amsellem S; Mehrpour M; Larghero J; Soler E; Naguibneva I; Pflumio F
Stem Cells; 2015 Jul; 33(7):2268-79. PubMed ID: 25858676
[TBL] [Abstract][Full Text] [Related]
14. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
15. UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia.
Benyoucef A; Palii CG; Wang C; Porter CJ; Chu A; Dai F; Tremblay V; Rakopoulos P; Singh K; Huang S; Pflumio F; Hébert J; Couture JF; Perkins TJ; Ge K; Dilworth FJ; Brand M
Genes Dev; 2016 Mar; 30(5):508-21. PubMed ID: 26944678
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
17. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
19. NF-kappaB activation in premalignant mouse tal-1/scl thymocytes and tumors.
O'Neil J; Ventura JJ; Cusson N; Kelliher M
Blood; 2003 Oct; 102(7):2593-6. PubMed ID: 12816868
[TBL] [Abstract][Full Text] [Related]
20. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]